LEVETIRACETAM DEXCEL 750

Valsts: Izraēla

Valoda: angļu

Klimata pārmaiņas: Ministry of Health

Aktīvā sastāvdaļa:

LEVETIRACETAM

Pieejams no:

DEXCEL PHARMA TECHNOLOGIES LTD

ATĶ kods:

N03AX14

Zāļu forma:

TABLETS

Kompozīcija:

LEVETIRACETAM 750 MG

Ievadīšanas:

PER OS

Receptes veids:

Required

Ražojis:

DEXCEL LTD, ISRAEL

Ārstniecības grupa:

LEVETIRACETAM

Ārstniecības joma:

LEVETIRACETAM

Ārstēšanas norādes:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

Autorizācija datums:

2018-03-31